NCT00064532View on ClinicalTrials.gov

Serum Sex Hormone Levels and Subclinical Atherosclerosis - Ancillary to MESA

CompletedOBSERVATIONAL
Enrollment

6,173

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Cardiovascular DiseasesAtherosclerosisCoronary ArteriosclerosisCoronary DiseaseHeart Diseases
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Northwestern University

OTHER

NCT00064532 - Serum Sex Hormone Levels and Subclinical Atherosclerosis - Ancillary to MESA | Biotech Hunter | Biotech Hunter